Complementary cancer therapy with standardized mistletoe extracts. Results of a controlled prospective multicentric randomized clinical trial;Komplementäre Tumor-therapie mit standardisiertem mistelgesamtextrakt: Ergebnisse einer kontrollierten prospektiv-randomisierten klinischen multicenterstudie

Deutsche Zeitschrift fur Onkologie

Volumn 35, Issue 4, 2003, Pages 186-194

  Schierholz, Jörg M ^a,h   Piao, B K ^b   Wang, Y X ^c   Xie, G R ^d   Mansmann, U ^e   Matthes, H ^f   Beuth, J ^g   Lin, H S ^a  

^a Helixor Heilmittel GmbH and Co KG   (Germany)

^b Guanganmen Hospital   (China)

^c LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^d Department of Breast Cancer   (China)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f Gemeinschaftskrankenhaus Havelhohe   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

^h NONE   (Germany)

Author keywords

Adverse effects; Mistletoe extracts; Multicentric randomized clinical trial; Quality of life; Standard chemotherapy

Indexed keywords

IMMUNOMODULATING AGENT; VISCUM ALBUM EXTRACT;

ALTERNATIVE MEDICINE; ANGIONEUROTIC EDEMA; APPETITE DISORDER; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEVER; HUMAN; INFLAMMATION; INJECTION PAIN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0346096490     PISSN: 16175891     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-814594     Document Type: Article

References (9)

1. Beuth J.: Grundlagen der Komplementäronkologie. Theorie und Praxis. Stuttgart: Hippokrates Verlag; 2002.
2. Wagner H.: Viscum album-die Mistel. Deutsche Apotheker Zeitung 124 (1984) 1429-1432.
3. Büssing A.: Biologische Wirkungen der Mistel. Zeitschrift für Onkologie 31 (1999) 35-43.
4. Büssing A.: Mistletoe. The Genus Viscum. Singapore: Harwood Academic Publishers; 2000.
5. Beuth J.: Clinical Relevance of Immunoactive Mistletoe Lectin-1. Anti Cancer Drugs 8 (1997) 53-55.
6. Schierholz J., Schlodder D.: Komplementäre Tumortherapie mit Mistelextrakten. Deutsche Zeitschrift für Onkologie 35 (2003) 124-133.
7. Nakano H., Namatame K., Nemoto H., Motohashi H., Nishiyama K., and Kumada K.: A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Hepato-Gastroenterology 46 (1999) 2662-2668.
8. Kienle G. S., Berrino F., Büssing A., Portalupi E., Rosenzweig S., and Kiene H.: Mistletoe in cancer - a systematic review in controlled clinical trials. European Journal of Medical Research 8 (2003) 109-119.
9. Nygren P., Glimelius B.: The Swedish Council on Technology Assessment in Health Care (SBU) report on cancer chemotherapy project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation. Acta Oncol. 40 (2/3) (2001) 155-165.